Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ADC Contract Manufacturing Market Report 2026 (7th Edition) | Commercial Scale Dominates ADC Manufacturing with 90% Market Share | A Clear Analysis of Market Trends, Drivers, Challenges, and Opportunities

globenewswire.com
ABBV AbbVie is mentioned as a key player in ADC contract manufacturing, indicating its involvement in a growing market. However, the article doesn't provide specific performance data or outlook for AbbVie itself.

ADC Contract Manufacturing Market Report 2026 (7th Edition) | Commercial Scale Dominates ADC Manufacturing with 90% Market Share | A Clear Analysis of Market Trends, Drivers, Challenges, and Opportunities Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "ADC Contract Manufacturing Market (7th Edition): Distribution by Stage of Development, Process Component, Type of Payload, Antibody Isotype, Target Indication, Antibody Origin, Type of Linker, and Key Geographical Regions - Industry Trends and Forecast 2025-2035" has been added to ResearchAndMarkets.com's offering.

The ADC contract manufacturing market is projected to grow from USD 2.13 billion to USD 3.21 billion by 2035, reflecting a CAGR of 4.6%. Antibody drug conjugates (ADCs) are increasingly becoming pivotal in cancer treatments, thanks to their stability, specificity, and tumor selectivity. The current pipeline features over 614 clinical candidates and 28 approved ADC programs. As production processes are complex and resource-intensive, many developers are outsourcing to ADC contract manufacturers, which is expected to drive market expansion during the forecast period.

Market Dynamics

With 35 companies specializing in ADC manufacturing globally, the majority offer comprehensive services, addressing challenges like technological transfers and scale-ups. Continuous upgrades in capabilities by stakeholders offer a competitive edge, supported by rising partnerships-60% forged in the last three years. Over 780 clinical trials for ADCs are underway, highlighting the expanding focus on safe and effective cancer treatments. Much of this momentum is concentrated in North America, underscoring its advanced manufacturing infrastructure. The projected growth in ADC therapeutics will further escalate demand for outsourcing manufacturing services.

Regional and Segment Insights:

Industry Key Players

Leading companies: AbbVie Contract Manufacturing, Abzena, CARBOGEN AMCIS, Catalent Pharma Solutions, Cerbios-Pharma, MabPlex, Millipore Sigma, Lonza, WuXi Biologics.

Research Insights:

Report Utility:

For more information about this report visit https://www.researchandmarkets.com/r/m68xuu

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.